Patent · US Active

Monoclonal antibody and a method thereof

US11981743B2 · kind B2 · utility

0Cited by

20References

11Claims

0Family size

Assignees

Biocon Ltd. · IN
Centro de Inmunología Molecular · CU

Inventors

Ramakrishnan Melarkode · Savanuru, IN
Pradip Nair · Savanuru, IN
Sundaraj David Rajkumar · Poonamallee, IN
Kedarnath Sastry · Savanuru, IN
Monalisa Chatterji · Bengaluru, IN
Laxmi Adhikary · Savanuru, IN
Hema Balasubramanian · Bengaluru, IN
Jose Enrique Montero Casimiro · Boyeros, CU
Josefa Lombardero Valladares · Boyeros, CU
Rolando Perez Rodriguez · Havana, CU

Key dates

Filing date	Apr 29, 2020
Grant date	May 14, 2024
Priority date	—
Expiry date	Jan 26, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.